Healthcare Sector Stocks
The Healthcare sector has a total of 1046 stocks, with a combined market cap of $9.19 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.06.
Market Cap
9.19T
Revenue
4.67T
Profits
191.23B
PE Ratio
48.06
Profit Margin
4.10%
Dividend Yield
0.39%
1046 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | -2.33% | 3,410,349 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 638.00B | -1.06% | 6,343,704 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 462.26B | -0.65% | 4,389,161 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 358.50B | -2.66% | 10,230,768 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 329.49B | -2.10% | 4,794,159 | 450.53B |
| 6 | NVS | Novartis AG | 273.28B | -2.15% | 3,062,096 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 252.87B | -1.67% | 2,225,476 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 249.60B | -0.67% | 2,323,587 | 46.34B |
| 9 | AMGN | Amgen Inc. | 227.88B | -0.50% | 3,130,965 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 184.82B | -1.47% | 5,357,405 | 30.46B |
| 11 | ABT | Abbott Laboratories | 171.01B | -2.10% | 7,571,496 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 170.17B | -1.04% | 21,556,021 | 50.34B |
| 13 | PFE | Pfizer Inc. | 162.55B | -0.70% | 33,638,991 | 63.70B |
| 14 | DHR | Danaher Corporation | 155.75B | -1.84% | 5,248,448 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 143.65B | -1.35% | 1,658,874 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 132.51B | -0.74% | 1,146,003 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 127.47B | -0.73% | 15,868,081 | 49.19B |
| 18 | MDT | Medtronic plc | 110.38B | -0.92% | 26,616,705 | 37.54B |
| 19 | CVS | CVS Health Corporation | 109.59B | -1.62% | 8,379,830 | 412.65B |
| 20 | SYK | Stryker Corporation | 105.63B | -0.90% | 2,930,242 | 25.84B |
| 21 | MCK | McKesson Corporation | 99.55B | -1.27% | 696,936 | 410.98B |
| 22 | SNY | Sanofi | 98.83B | 1.20% | 4,304,668 | 55.89B |
| 23 | GSK | GSK plc | 97.46B | -2.39% | 5,852,600 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 92.39B | -1.13% | 1,238,201 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 84.32B | -1.00% | 1,303,669 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 76.88B | -5.35% | 20,649,483 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 75.72B | 1.03% | 872,457 | 15.53B |
| 28 | CI | The Cigna Group | 71.83B | -1.25% | 3,080,212 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 63.26B | -0.52% | 17,967,901 | 21.00B |
| 30 | ARGX | argenx SE | 60.14B | -1.21% | 243,748 | 5.32B |
| 31 | NTRA | Natera, Inc. | 59.58B | -0.29% | 1,851,431 | 2.71B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 58.73B | -1.73% | 2,102,759 | 28.42B |
| 33 | COR | Cencora, Inc. | 57.30B | -2.39% | 1,811,106 | 332.77B |
| 34 | CAH | Cardinal Health, Inc. | 51.52B | -0.63% | 1,944,992 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 49.75B | -2.00% | 4,893,869 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 48.76B | -1.63% | 1,798,603 | 22.48B |
| 37 | A | Agilent Technologies, Inc. | 48.58B | -1.55% | 2,590,365 | 7.37B |
| 38 | VEEV | Veeva Systems Inc. | 46.22B | 2.47% | 1,755,675 | 3.46B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 46.15B | -0.53% | 5,654,694 | 17.32B |
| 40 | HUM | Humana Inc. | 45.82B | -1.37% | 1,312,737 | 145.68B |
| 41 | MDLN | Medline Inc. | 45.62B | -0.80% | 9,099,900 | 29.94B |
| 42 | IQV | IQVIA Holdings Inc. | 44.25B | -0.05% | 1,527,505 | 16.98B |
| 43 | RVMD | Revolution Medicines, Inc. | 43.99B | 0.38% | 1,845,956 | - |
| 44 | WAT | Waters Corporation | 43.17B | -0.87% | 666,024 | 4.64B |
| 45 | ONC | BeOne Medicines AG | 41.61B | 0.18% | 328,879 | 6.13B |
| 46 | ILMN | Illumina, Inc. | 41.33B | 0.62% | 2,939,287 | 4.49B |
| 47 | IDXX | IDEXX Laboratories, Inc. | 41.14B | -2.11% | 503,526 | 4.55B |
| 48 | HLN | Haleon plc | 39.48B | -0.77% | 17,749,500 | 14.80B |
| 49 | RPRX | Royalty Pharma plc | 33.56B | 0.24% | 3,653,750 | 2.54B |
| 50 | BIIB | Biogen Inc. | 33.37B | -0.52% | 1,553,331 | 10.03B |
| 51 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.02B | -2.89% | 1,044,414 | 4.80B |
| 52 | DXCM | DexCom, Inc. | 32.56B | -0.40% | 3,474,453 | 4.97B |
| 53 | RMD | ResMed Inc. | 31.63B | -0.78% | 1,308,168 | 5.65B |
| 54 | ALC | Alcon Inc. | 31.27B | -1.05% | 1,603,864 | 10.86B |
| 55 | CNC | Centene Corporation | 30.69B | -0.14% | 3,641,378 | 180.30B |
| 56 | MTD | Mettler-Toledo International Inc. | 30.27B | -1.72% | 153,915 | 4.13B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 29.53B | -1.64% | 2,727,759 | 21.27B |
| 58 | ZTS | Zoetis Inc. | 28.86B | -0.67% | 4,444,526 | 9.53B |
| 59 | ROIV | Roivant Sciences Ltd. | 26.42B | 0.19% | 5,282,357 | 7.53M |
| 60 | WST | West Pharmaceutical Services, Inc. | 26.09B | -1.56% | 471,177 | 3.33B |
| 61 | DGX | Quest Diagnostics Incorporated | 25.72B | 0.47% | 1,093,356 | 11.56B |
| 62 | LH | Labcorp Holdings Inc. | 24.99B | -0.23% | 646,179 | 14.35B |
| 63 | INSM | Insmed Incorporated | 24.93B | -1.29% | 2,870,339 | 1.14B |
| 64 | BNTX | BioNTech SE | 24.69B | -0.27% | 845,548 | 3.03B |
| 65 | INCY | Incyte Corporation | 24.60B | -1.50% | 1,619,920 | 5.82B |
| 66 | PHG | Koninklijke Philips N.V. | 24.00B | -1.37% | 1,185,716 | 20.18B |
| 67 | GH | Guardant Health, Inc. | 23.94B | 0.35% | 1,583,284 | 1.18B |
| 68 | UTHR | United Therapeutics Corporation | 23.24B | 12.55% | 3,336,748 | 3.15B |
| 69 | GMAB | Genmab A/S | 21.27B | 0.30% | 5,154,579 | 4.13B |
| 70 | THC | Tenet Healthcare Corporation | 20.58B | -0.79% | 580,158 | 21.81B |
| 71 | STE | STERIS plc | 20.48B | -0.30% | 560,817 | 6.04B |
| 72 | VTRS | Viatris Inc. | 20.35B | -2.21% | 11,806,881 | 14.74B |
| 73 | MEDP | Medpace Holdings, Inc. | 17.42B | 0.33% | 306,610 | 2.78B |
| 74 | RVTY | Revvity, Inc. | 17.06B | 0.08% | 4,456,011 | 2.91B |
| 75 | ZBH | Zimmer Biomet Holdings, Inc. | 16.94B | -2.49% | 2,580,476 | 8.51B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.03B | -0.36% | 1,001,948 | 4.60B |
| 77 | SOLV | Solventum Corporation | 15.01B | -1.31% | 689,740 | 8.31B |
| 78 | ASND | Ascendis Pharma A/S | 14.96B | -0.11% | 926,230 | 1.20B |
| 79 | TEM | Tempus AI, Inc. | 14.78B | -0.82% | 4,576,139 | 1.43B |
| 80 | EXEL | Exelixis, Inc. | 14.47B | -0.41% | 3,065,022 | 2.44B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 14.42B | 2.52% | 1,847,009 | 3.37B |
| 82 | CRL | Charles River Laboratories International, Inc. | 14.08B | -0.32% | 799,359 | 4.00B |
| 83 | SMMT | Summit Therapeutics Inc. | 13.49B | 3.17% | 13,060,430 | - |
| 84 | ICLR | ICON Public Limited Company | 13.12B | -0.21% | 851,064 | 8.29B |
| 85 | BBIO | BridgeBio Pharma, Inc. | 12.86B | -0.26% | 2,822,431 | 713.07M |
| 86 | PEN | Penumbra, Inc. | 12.54B | -0.16% | 378,220 | 1.50B |
| 87 | HALO | Halozyme Therapeutics, Inc. | 12.53B | -1.04% | 3,521,136 | 1.66B |
| 88 | CORT | Corcept Therapeutics Incorporated | 12.46B | 0.43% | 910,311 | 830.81M |
| 89 | BAX | Baxter International Inc. | 12.41B | 2.21% | 8,727,221 | 11.47B |
| 90 | TWST | Twist Bioscience Corporation | 12.12B | 3.82% | 3,254,952 | 431.80M |
| 91 | EHC | Encompass Health Corporation | 11.99B | -1.68% | 897,460 | 6.21B |
| 92 | FMS | Fresenius Medical Care AG | 11.91B | 0.49% | 1,067,087 | 22.19B |
| 93 | BTSG | BrightSpring Health Services, Inc. | 11.82B | 1.90% | 2,161,274 | 14.37B |
| 94 | TXG | 10x Genomics, Inc. | 11.77B | 0.36% | 3,750,804 | 616.91M |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.64B | -1.08% | 262,462 | 1.28B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 11.61B | 0.22% | 1,797,910 | 3.41B |
| 97 | TECH | Bio-Techne Corporation | 11.36B | 0.12% | 3,138,664 | 1.22B |
| 98 | SNN | Smith & Nephew plc | 11.27B | 0.04% | 1,183,213 | 6.30B |
| 99 | ELAN | Elanco Animal Health Incorporated | 11.19B | -0.97% | 5,364,870 | 5.02B |
| 100 | DVA | DaVita Inc. | 11.15B | -0.15% | 533,271 | 14.01B |
| 101 | RGEN | Repligen Corporation | 10.85B | -1.20% | 730,435 | 785.10M |
| 102 | COO | The Cooper Companies, Inc. | 10.75B | -0.18% | 4,894,854 | 4.24B |
| 103 | RDY | Dr. Reddy's Laboratories Limited | 10.74B | -1.79% | 3,936,358 | 3.50B |
| 104 | ALGN | Align Technology, Inc. | 10.33B | 0.93% | 917,822 | 4.14B |
| 105 | UHS | Universal Health Services, Inc. | 10.27B | -0.84% | 613,512 | 18.11B |
| 106 | AVTR | Avantor, Inc. | 10.18B | -1.25% | 7,378,761 | 6.56B |
| 107 | BIO | Bio-Rad Laboratories, Inc. | 10.10B | -0.48% | 228,589 | 2.59B |
| 108 | GMED | Globus Medical, Inc. | 10.06B | -1.04% | 1,249,633 | 3.14B |
| 109 | IBRX | ImmunityBio, Inc. | 10.00B | 6.91% | 27,286,818 | 165.79M |
| 110 | ENSG | The Ensign Group, Inc. | 9.94B | -1.98% | 317,045 | 5.49B |
| 111 | BRKR | Bruker Corporation | 9.87B | 0.37% | 2,138,854 | 3.50B |
| 112 | MOH | Molina Healthcare, Inc. | 9.85B | -0.15% | 510,885 | 42.47B |
| 113 | KRYS | Krystal Biotech, Inc. | 9.84B | -0.75% | 268,266 | 440.48M |
| 114 | GKOS | Glaukos Corporation | 9.68B | 3.56% | 947,091 | 612.84M |
| 115 | AXSM | Axsome Therapeutics, Inc. | 9.66B | -0.94% | 1,033,881 | 776.57M |
| 116 | OSCR | Oscar Health, Inc. | 9.51B | 3.59% | 5,446,048 | 15.32B |
| 117 | HSIC | Henry Schein, Inc. | 9.36B | -1.18% | 883,513 | 13.60B |
| 118 | KYMR | Kymera Therapeutics, Inc. | 9.30B | 1.16% | 1,022,621 | 105.00M |
| 119 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.25B | -1.21% | 1,742,748 | 669.50M |
| 120 | CYTK | Cytokinetics, Incorporated | 9.16B | 0.41% | 2,977,682 | 67.67M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.12B | -0.06% | 787,658 | 281.99M |
| 122 | QGEN | Qiagen N.V. | 9.05B | -1.44% | 2,322,703 | 2.10B |
| 123 | PODD | Insulet Corporation | 9.05B | -1.78% | 1,416,042 | 3.05B |
| 124 | ABVX | ABIVAX Société Anonyme | 8.69B | 0.53% | 886,231 | 5.33M |
| 125 | CAI | Caris Life Sciences, Inc. | 8.66B | -2.92% | 2,929,551 | 989.61M |
| 126 | PCVX | Vaxcyte, Inc. | 8.47B | 0.37% | 1,508,716 | - |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 8.13B | 3.64% | 710,563 | 7.46M |
| 128 | TGTX | TG Therapeutics, Inc. | 7.91B | -0.73% | 1,908,215 | 799.54M |
| 129 | SYRE | Spyre Therapeutics, Inc. | 7.85B | 5.09% | 2,096,144 | - |
| 130 | HNGE | Hinge Health, Inc. | 7.85B | 2.13% | 1,634,924 | 720.06M |
| 131 | ATR | AptarGroup, Inc. | 7.70B | -1.73% | 424,123 | 3.93B |
| 132 | IONS | Ionis Pharmaceuticals, Inc. | 7.42B | -2.70% | 2,630,197 | 874.09M |
| 133 | HQY | HealthEquity, Inc. | 7.32B | 1.39% | 908,848 | 1.36B |
| 134 | AMRX | Amneal Pharmaceuticals, Inc. | 7.01B | -0.30% | 4,104,924 | 3.12B |
| 135 | IMVT | Immunovant, Inc. | 6.98B | 0.96% | 1,433,917 | - |
| 136 | HIMS | Hims & Hers Health, Inc. | 6.95B | 3.80% | 14,520,467 | 2.58B |
| 137 | BLTE | Belite Bio, Inc | 6.84B | 1.90% | 142,077 | - |
| 138 | ALKS | Alkermes plc | 6.80B | -0.69% | 2,527,216 | 1.67B |
| 139 | IOVA | Iovance Biotherapeutics, Inc. | 6.71B | 2.56% | 29,341,687 | 324.97M |
| 140 | PACS | PACS Group, Inc. | 6.58B | -1.66% | 856,348 | 5.55B |
| 141 | CHE | Chemed Corporation | 6.57B | -1.36% | 155,939 | 2.60B |
| 142 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.56B | -0.52% | 737,178 | 239.92M |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.50B | 0.02% | 1,806,262 | 1.56B |
| 144 | GRFS | Grifols, S.A. | 6.50B | 0.14% | 772,969 | 8.48B |
| 145 | CGON | CG Oncology, Inc. | 6.28B | 0.52% | 1,330,930 | 6.23M |
| 146 | GRAL | GRAIL, Inc. | 6.26B | 2.60% | 1,923,794 | 165.26M |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 6.23B | 0.65% | 505,862 | 290.54M |
| 148 | BLCO | Bausch + Lomb Corporation | 6.07B | -0.82% | 232,486 | 5.32B |
| 149 | KOD | Kodiak Sciences Inc. | 5.95B | 4.04% | 4,920,040 | - |
| 150 | SRRK | Scholar Rock Holding Corporation | 5.88B | 1.19% | 1,285,235 | - |
| 151 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.82B | -1.48% | 650,611 | 840.85M |
| 152 | STVN | Stevanato Group S.p.A. | 5.73B | -1.04% | 192,809 | 1.40B |
| 153 | COGT | Cogent Biosciences, Inc. | 5.56B | 1.14% | 1,960,173 | - |
| 154 | MIRM | Mirum Pharmaceuticals, Inc. | 5.55B | -2.35% | 901,734 | 618.07M |
| 155 | TVTX | Travere Therapeutics, Inc. | 5.55B | -1.85% | 1,560,569 | 591.33M |
| 156 | ORKA | Oruka Therapeutics, Inc. | 5.51B | 1.39% | 1,535,623 | - |
| 157 | MMED | MiniMed Group, Inc. | 5.48B | -2.84% | 4,024,549 | 3.22B |
| 158 | RDNT | RadNet, Inc. | 5.43B | -2.42% | 621,241 | 2.27B |
| 159 | PTCT | PTC Therapeutics, Inc. | 5.41B | -0.28% | 1,043,320 | 1.01B |
| 160 | CRSP | CRISPR Therapeutics AG | 5.35B | -1.21% | 1,169,341 | 13.39M |
| 161 | TFX | Teleflex Incorporated | 5.30B | -1.01% | 644,720 | 2.25B |
| 162 | SHC | Sotera Health Company | 5.28B | -0.59% | 2,029,156 | 1.22B |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.15B | -1.87% | 634,202 | 1.58B |
| 164 | ERAS | Erasca, Inc. | 5.13B | 3.17% | 5,286,619 | - |
| 165 | DFTX | Definium Therapeutics, Inc. | 5.11B | -0.39% | 2,380,950 | - |
| 166 | MANE | Veradermics, Incorporated | 5.07B | 2.89% | 689,730 | - |
| 167 | DOCS | Doximity, Inc. | 5.05B | 6.86% | 4,955,433 | 655.57M |
| 168 | BLLN | BillionToOne, Inc. | 5.02B | -9.93% | 968,839 | 397.41M |
| 169 | DNTH | Dianthus Therapeutics, Inc. | 4.93B | 1.02% | 1,030,796 | 1.90M |
| 170 | WAY | Waystar Holding Corp. | 4.86B | 1.08% | 2,024,024 | 1.21B |
| 171 | HAE | Haemonetics Corporation | 4.79B | -0.47% | 508,904 | 1.35B |
| 172 | ABCL | AbCellera Biologics Inc. | 4.73B | -1.55% | 4,863,813 | 66.17M |
| 173 | ADPT | Adaptive Biotechnologies Corporation | 4.61B | 0.45% | 1,508,275 | 308.08M |
| 174 | LFST | LifeStance Health Group, Inc. | 4.60B | 1.18% | 3,292,409 | 1.58B |
| 175 | EWTX | Edgewise Therapeutics, Inc. | 4.41B | 3.60% | 1,678,340 | - |
| 176 | CON | Concentra Group Holdings Parent, Inc. | 4.39B | -2.60% | 1,088,578 | 2.29B |
| 177 | HTFL | HeartFlow, Inc. | 4.33B | -0.16% | 1,297,253 | 212.07M |
| 178 | ITGR | Integer Holdings Corporation | 4.29B | 0.02% | 681,708 | 1.84B |
| 179 | INDV | Indivior Pharmaceuticals, Inc. | 4.23B | -2.02% | 1,673,587 | 1.33B |
| 180 | LIVN | LivaNova PLC | 4.21B | -0.64% | 970,701 | 1.47B |
| 181 | TNGX | Tango Therapeutics, Inc. | 4.21B | 2.17% | 3,660,636 | 53.81M |
| 182 | ICUI | ICU Medical, Inc. | 4.01B | -1.79% | 307,246 | 2.16B |
| 183 | PBLS | Parabilis Medicines, Inc. | 3.99B | 1.19% | 547,140 | 148.00K |
| 184 | RLAY | Relay Therapeutics, Inc. | 3.96B | -1.69% | 2,782,511 | 10.35M |
| 185 | CELC | Celcuity Inc. | 3.89B | 2.77% | 2,555,386 | - |
| 186 | LEGN | Legend Biotech Corporation | 3.85B | 5.69% | 2,955,980 | 1.27B |
| 187 | VKTX | Viking Therapeutics, Inc. | 3.80B | 2.48% | 7,000,091 | - |
| 188 | NVST | Envista Holdings Corporation | 3.77B | 0.60% | 2,005,031 | 2.86B |
| 189 | IRTC | iRhythm Holdings, Inc. | 3.75B | -0.49% | 339,817 | 825.34M |
| 190 | TLX | Telix Pharmaceuticals Limited | 3.71B | -3.26% | 344,245 | 890.79M |
| 191 | IDYA | IDEAYA Biosciences, Inc. | 3.71B | 1.48% | 1,016,446 | 234.13M |
| 192 | VCYT | Veracyte, Inc. | 3.70B | -0.09% | 1,184,281 | 561.90M |
| 193 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.65B | -0.61% | 1,307,046 | -665.00K |
| 194 | XENE | Xenon Pharmaceuticals Inc. | 3.60B | -0.16% | 2,466,583 | 7.50M |
| 195 | OGN | Organon & Co. | 3.60B | -0.29% | 2,066,468 | 6.13B |
| 196 | PLSE | Pulse Biosciences, Inc. | 3.56B | -1.91% | 604,608 | 1.19M |
| 197 | ACAD | Acadia Pharmaceuticals Inc. | 3.47B | -0.35% | 3,134,008 | 1.14B |
| 198 | TARS | Tarsus Pharmaceuticals, Inc. | 3.45B | 2.50% | 1,562,882 | 606.33M |
| 199 | NHC | National HealthCare Corporation | 3.44B | -1.78% | 116,839 | 1.56B |
| 200 | WRBY | Warby Parker Inc. | 3.43B | 1.13% | 4,100,535 | 911.61M |
| 201 | OPCH | Option Care Health, Inc. | 3.37B | -1.40% | 1,570,761 | 5.69B |
| 202 | CDNA | CareDx, Inc. | 3.36B | 1.53% | 1,768,555 | 458.09M |
| 203 | ELVN | Enliven Therapeutics, Inc. | 3.36B | -1.44% | 800,171 | - |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.32B | -1.20% | 2,391,395 | 463.98M |
| 205 | DNLI | Denali Therapeutics Inc. | 3.30B | -0.67% | 2,255,592 | 3.60M |
| 206 | RCUS | Arcus Biosciences, Inc. | 3.29B | 0.70% | 1,361,917 | 117.00M |
| 207 | RGC | Regencell Bioscience Holdings Limited | 3.08B | 0.32% | 56,129 | - |
| 208 | PGEN | Precigen, Inc. | 3.06B | 6.34% | 11,685,478 | 85.72M |
| 209 | DYN | Dyne Therapeutics, Inc. | 3.01B | -0.62% | 4,456,484 | - |
| 210 | ZLAB | Zai Lab Limited | 2.96B | 1.58% | 830,831 | 449.61M |
| 211 | NAMS | NewAmsterdam Pharma Company N.V. | 2.91B | 2.14% | 2,270,418 | 7.12M |
| 212 | TMDX | TransMedics Group, Inc. | 2.89B | -0.74% | 566,805 | 668.47M |
| 213 | ATRC | AtriCure, Inc. | 2.86B | -3.19% | 1,111,186 | 569.62M |
| 214 | MBX | MBX Biosciences, Inc. | 2.82B | 1.51% | 523,793 | - |
| 215 | NEOG | Neogen Corporation | 2.79B | 0.55% | 6,887,000 | 870.40M |
| 216 | LQDA | Liquidia Corporation | 2.71B | -57.19% | 22,953,196 | 450.91M |
| 217 | AVAH | Aveanna Healthcare Holdings Inc. | 2.71B | -2.90% | 5,800,501 | 2.60B |
| 218 | BKD | Brookdale Senior Living Inc. | 2.59B | -1.37% | 6,760,714 | 2.93B |
| 219 | HCM | HUTCHMED (China) Limited | 2.58B | 3.39% | 78,126 | 549.12M |
| 220 | GRDN | Guardian Pharmacy Services, Inc. | 2.58B | 0.25% | 540,209 | 1.46B |
| 221 | ACHC | Acadia Healthcare Company, Inc. | 2.56B | -1.93% | 1,365,734 | 3.37B |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.55B | 2.43% | 2,502,809 | 158.00K |
| 223 | PRVA | Privia Health Group, Inc. | 2.52B | 0.36% | 1,335,256 | 2.36B |
| 224 | IRON | Disc Medicine, Inc. | 2.51B | -0.62% | 671,490 | - |
| 225 | SUPN | Supernus Pharmaceuticals, Inc. | 2.50B | -2.12% | 685,590 | 830.44M |
| 226 | SLS | SELLAS Life Sciences Group, Inc. | 2.49B | 6.95% | 8,618,722 | - |
| 227 | NRIX | Nurix Therapeutics, Inc. | 2.46B | 0.13% | 2,010,651 | 36.77M |
| 228 | AXGN | Axogen, Inc. | 2.46B | -1.23% | 1,089,098 | 251.17M |
| 229 | BEAM | Beam Therapeutics Inc. | 2.44B | -0.29% | 1,559,294 | 156.04M |
| 230 | IMNM | Immunome, Inc. | 2.44B | -1.74% | 1,306,306 | 4.02M |
| 231 | BFLY | Butterfly Network, Inc. | 2.39B | -1.54% | 4,562,283 | 112.14M |
| 232 | ALMR | Alamar Biosciences, Inc. | 2.36B | 4.35% | 741,823 | 100.42M |
| 233 | NEO | NeoGenomics, Inc. | 2.36B | -2.03% | 2,473,562 | 766.30M |
| 234 | VRDN | Viridian Therapeutics, Inc. | 2.33B | 2.95% | 1,404,853 | 71.13M |
| 235 | VERA | Vera Therapeutics, Inc. | 2.33B | -0.28% | 1,800,119 | - |
| 236 | SDGR | Schrödinger, Inc. | 2.32B | 2.37% | 3,894,110 | 259.04M |
| 237 | UFPT | UFP Technologies, Inc. | 2.30B | -0.03% | 140,976 | 631.64M |
| 238 | CLOV | Clover Health Investments, Corp. | 2.29B | -0.35% | 3,341,495 | 2.48B |
| 239 | HRMY | Harmony Biosciences Holdings, Inc. | 2.29B | -0.08% | 667,692 | 959.90M |
| 240 | ADMA | ADMA Biologics, Inc. | 2.25B | 0.70% | 2,699,132 | 512.28M |
| 241 | GPCR | Structure Therapeutics Inc. | 2.23B | -4.34% | 2,197,313 | - |
| 242 | PHVS | Pharvaris N.V. | 2.23B | -0.03% | 839,837 | - |
| 243 | MLYS | Mineralys Therapeutics, Inc. | 2.22B | 2.66% | 2,051,880 | - |
| 244 | RXRX | Recursion Pharmaceuticals, Inc. | 2.21B | 2.48% | 32,785,908 | 54.86M |
| 245 | BHC | Bausch Health Companies Inc. | 2.18B | 0.52% | 1,457,638 | 10.85B |
| 246 | PBH | Prestige Consumer Healthcare Inc. | 2.17B | -1.86% | 583,492 | 1.10B |
| 247 | WGS | GeneDx Holdings Corp. | 2.16B | -4.60% | 905,171 | 454.43M |
| 248 | AUPH | Aurinia Pharmaceuticals Inc. | 2.15B | -1.37% | 913,844 | 311.51M |
| 249 | ADRX | ADARx Pharmaceuticals, Inc. | 2.13B | -3.39% | 788,842 | 6.13M |
| 250 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.13B | 0.73% | 13,099,017 | 940.61M |
| 251 | TRLV | Trulieve Cannabis Corp. | 2.10B | -12.17% | 8,369,895 | 1.14B |
| 252 | ALVO | Alvotech | 2.07B | -2.03% | 1,136,285 | 494.61M |
| 253 | NKTR | Nektar Therapeutics | 2.07B | 2.20% | 1,210,000 | 54.59M |
| 254 | VCEL | Vericel Corporation | 2.06B | -1.16% | 585,379 | 306.30M |
| 255 | PRGO | Perrigo Company plc | 2.05B | -1.60% | 2,548,740 | 4.14B |
| 256 | MD | Pediatrix Medical Group, Inc. | 2.04B | -1.27% | 779,502 | 1.95B |
| 257 | TRVI | Trevi Therapeutics, Inc. | 2.04B | -0.69% | 2,725,678 | - |
| 258 | ADUS | Addus HomeCare Corporation | 2.02B | -2.14% | 330,871 | 1.48B |
| 259 | BHVN | Biohaven Ltd. | 2.02B | 0.45% | 1,432,116 | - |
| 260 | INSP | Inspire Medical Systems, Inc. | 2.01B | -5.22% | 1,002,283 | 898.74M |
| 261 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.99B | 0.13% | 3,606,276 | 208.78M |
| 262 | PVLA | Palvella Therapeutics, Inc. | 1.99B | -0.77% | 262,310 | - |
| 263 | URGN | UroGen Pharma Ltd. | 1.99B | 0.44% | 641,378 | 188.73M |
| 264 | AGIO | Agios Pharmaceuticals, Inc. | 1.99B | -0.15% | 1,548,456 | 98.34M |
| 265 | NUVB | Nuvation Bio Inc. | 1.97B | -0.36% | 5,549,484 | 169.90M |
| 266 | LKFT | Lakefront Biotherapeutics NV | 1.95B | 0.44% | 188,590 | 1.13B |
| 267 | PGNY | Progyny, Inc. | 1.93B | 1.61% | 980,454 | 1.31B |
| 268 | GENB | Generate Biomedicines, Inc. | 1.93B | -2.59% | 733,241 | 26.48M |
| 269 | SRPT | Sarepta Therapeutics, Inc. | 1.92B | -2.25% | 1,995,000 | 1.97B |
| 270 | ESTA | Establishment Labs Holdings Inc. | 1.91B | 0.74% | 555,707 | 245.82M |
| 271 | MESO | Mesoblast Limited | 1.91B | -1.48% | 199,076 | 120.25M |
| 272 | BLFS | BioLife Solutions, Inc. | 1.90B | -0.94% | 1,094,005 | 106.69M |
| 273 | FTRE | Fortrea Holdings Inc. | 1.90B | 1.06% | 1,480,952 | 2.68B |
| 274 | VIR | Vir Biotechnology, Inc. | 1.89B | 4.98% | 1,737,683 | 303.23M |
| 275 | LMAT | LeMaitre Vascular, Inc. | 1.89B | -0.36% | 207,866 | 262.43M |
| 276 | ZYME | Zymeworks Inc. | 1.88B | -2.61% | 1,585,032 | 37.13M |
| 277 | NVCR | NovoCure Limited | 1.86B | -0.25% | 1,876,603 | 699.19M |
| 278 | XNCR | Xencor, Inc. | 1.86B | -0.20% | 1,541,989 | 104.97M |
| 279 | ABSI | Absci Corporation | 1.85B | 6.21% | 5,432,373 | 1.56M |
| 280 | SEPN | Septerna, Inc. | 1.83B | - | 209,580 | 98.88M |
| 281 | ASTH | Astrana Health, Inc. | 1.82B | 0.34% | 400,577 | 3.84B |
| 282 | SGRY | Surgery Partners, Inc. | 1.80B | -3.75% | 1,857,170 | 3.37B |
| 283 | NVAX | Novavax, Inc. | 1.78B | -0.09% | 4,565,584 | 413.80M |
| 284 | SNDA | Sonida Senior Living, Inc. | 1.78B | -0.08% | 365,712 | 481.07M |
| 285 | XRAY | DENTSPLY SIRONA Inc. | 1.77B | -1.34% | 6,547,676 | 3.64B |
| 286 | ZBIO | Zenas BioPharma, Inc. | 1.76B | 0.78% | 623,266 | 1.00M |
| 287 | XERS | Xeris Biopharma Holdings, Inc. | 1.74B | -4.21% | 3,753,453 | 335.41M |
| 288 | PSNL | Personalis, Inc. | 1.74B | -0.43% | 984,128 | 69.67M |
| 289 | CMPS | COMPASS Pathways plc | 1.72B | -4.01% | 3,052,123 | - |
| 290 | ALHC | Alignment Healthcare, Inc. | 1.69B | 3.16% | 8,787,158 | 4.58B |
| 291 | FRNM | Freenome, Inc. | 1.69B | -1.07% | 518,521 | 35.41M |
| 292 | NTLA | Intellia Therapeutics, Inc. | 1.69B | 0.25% | 5,318,300 | 59.51M |
| 293 | KMTS | Kestra Medical Technologies, Ltd. | 1.69B | -0.60% | 616,809 | 106.73M |
| 294 | OCUL | Ocular Therapeutix, Inc. | 1.68B | -2.54% | 4,568,575 | 52.06M |
| 295 | SNDX | Syndax Pharmaceuticals, Inc. | 1.68B | 3.07% | 1,729,352 | 252.25M |
| 296 | STOK | Stoke Therapeutics, Inc. | 1.68B | 0.46% | 1,874,752 | 27.59M |
| 297 | QURE | uniQure N.V. | 1.68B | -1.43% | 7,443,139 | 18.67M |
| 298 | RAPP | Rapport Therapeutics, Inc. | 1.61B | 1.76% | 582,027 | 20.00M |
| 299 | GHRS | GH Research PLC | 1.61B | -4.82% | 384,733 | - |
| 300 | ATEC | Alphatec Holdings, Inc. | 1.59B | -0.48% | 1,588,349 | 815.05M |
| 301 | NBTX | Nanobiotix S.A. | 1.59B | -1.08% | 311,374 | 13.15M |
| 302 | TSHA | Taysha Gene Therapies, Inc. | 1.59B | -2.40% | 3,901,852 | 5.49M |
| 303 | IMCR | Immunocore Holdings plc | 1.56B | -1.82% | 622,915 | 430.78M |
| 304 | ANIP | ANI Pharmaceuticals, Inc. | 1.56B | 0.04% | 383,956 | 978.38M |
| 305 | OMCL | Omnicell, Inc. | 1.55B | -0.76% | 592,462 | 1.25B |
| 306 | INVA | Innoviva, Inc. | 1.53B | 0.47% | 1,100,218 | 440.00M |
| 307 | AZTA | Azenta, Inc. | 1.53B | 1.78% | 929,061 | 613.81M |
| 308 | MAZE | Maze Therapeutics, Inc. | 1.51B | 0.59% | 518,011 | 20.00M |
| 309 | TYRA | Tyra Biosciences, Inc. | 1.50B | -0.50% | 1,034,685 | - |
| 310 | ANAB | AnaptysBio, Inc. | 1.50B | -0.22% | 1,430,101 | 106.09M |
| 311 | AVBP | ArriVent BioPharma, Inc. | 1.49B | 2.51% | 712,457 | - |
| 312 | KLRA | Kailera Therapeutics, Inc. | 1.48B | 3.91% | 1,368,805 | - |
| 313 | RARE | Ultragenyx Pharmaceutical Inc. | 1.48B | -1.89% | 4,422,693 | 717.00M |
| 314 | INBX | Inhibrx Biosciences, Inc. | 1.47B | -4.53% | 389,480 | 1.30M |
| 315 | ETON | Eton Pharmaceuticals, Inc. | 1.47B | -13.01% | 1,811,023 | 105.60M |
| 316 | ARDT | Ardent Health, Inc. | 1.46B | -2.27% | 363,302 | 6.41B |
| 317 | KRSA | Korsana Biosciences, Inc. | 1.46B | -5.88% | 121,133 | - |
| 318 | PAHC | Phibro Animal Health Corporation | 1.45B | 0.82% | 205,543 | 1.52B |
| 319 | NUTX | Nutex Health Inc. | 1.45B | 0.74% | 147,840 | 846.72M |
| 320 | AAPG | Ascentage Pharma Group International | 1.44B | 6.25% | 13,726 | 94.61M |
| 321 | COAG | Hemab Therapeutics Holdings, Inc. | 1.44B | -5.40% | 865,204 | - |
| 322 | HCSG | Healthcare Services Group, Inc. | 1.40B | -2.15% | 677,912 | 1.86B |
| 323 | CERT | Certara, Inc. | 1.40B | -0.65% | 3,417,706 | 421.75M |
| 324 | ORIC | ORIC Pharmaceuticals, Inc. | 1.40B | 0.75% | 1,961,192 | - |
| 325 | AMN | AMN Healthcare Services, Inc. | 1.39B | 2.63% | 1,042,321 | 3.43B |
| 326 | CNMD | CONMED Corporation | 1.38B | -0.99% | 290,077 | 1.37B |
| 327 | KARD | Kardigan, Inc. | 1.38B | 0.61% | 487,834 | - |
| 328 | OMER | Omeros Corporation | 1.38B | -1.09% | 1,365,766 | 38.42M |
| 329 | DRTS | Alpha Tau Medical Ltd. | 1.38B | -1.84% | 369,266 | - |
| 330 | PNTG | The Pennant Group, Inc. | 1.36B | -3.70% | 248,729 | 1.10B |
| 331 | AGL | agilon health, inc. | 1.34B | 1.84% | 327,322 | 5.92B |
| 332 | BRVE | Braveheart Bio, Inc. | 1.32B | -9.58% | 967,641 | - |
| 333 | DMRA | Damora Therapeutics, Inc. | 1.31B | 3.00% | 563,015 | - |
| 334 | SVRA | Savara Inc. | 1.31B | 1.57% | 6,051,743 | - |
| 335 | USPH | U.S. Physical Therapy, Inc. | 1.28B | -0.49% | 137,612 | 804.27M |
| 336 | OMDA | Omada Health, Inc. | 1.27B | 7.43% | 2,197,374 | 309.76M |
| 337 | TRAX | First Tracks Biotherapeutics, Inc. | 1.27B | -1.50% | 610,640 | - |
| 338 | IART | Integra LifeSciences Holdings Corporation | 1.27B | -2.16% | 768,910 | 1.65B |
| 339 | AVLN | Avalyn Pharma Inc. | 1.26B | 5.13% | 347,615 | - |
| 340 | MNKD | MannKind Corporation | 1.25B | 16.77% | 15,020,195 | 393.63M |
| 341 | REPL | Replimune Group, Inc. | 1.25B | 1.85% | 3,081,760 | - |
| 342 | LBRX | LB Pharmaceuticals Inc | 1.24B | 2.95% | 437,216 | - |
| 343 | BCAX | Bicara Therapeutics Inc. | 1.23B | 0.27% | 905,369 | - |
| 344 | CRON | Cronos Group Inc. | 1.22B | -2.37% | 1,820,935 | 179.09M |
| 345 | OPK | OPKO Health, Inc. | 1.20B | -0.62% | 2,387,534 | 587.90M |
| 346 | INNV | InnovAge Holding Corp. | 1.20B | -2.00% | 807,590 | 989.71M |
| 347 | IMTX | Immatics N.V. | 1.20B | 2.57% | 1,898,933 | 47.65M |
| 348 | HROW | Harrow, Inc. | 1.15B | -1.91% | 514,375 | 275.59M |
| 349 | BVS | Bioventus Inc. | 1.15B | -2.64% | 461,150 | 581.85M |
| 350 | TNDM | Tandem Diabetes Care, Inc. | 1.13B | -1.57% | 2,198,743 | 1.04B |
| 351 | STAA | STAAR Surgical Company | 1.13B | 0.80% | 798,872 | 339.59M |
| 352 | VOR | Vor Biopharma Inc. | 1.13B | 4.09% | 1,069,918 | - |
| 353 | GDRX | GoodRx Holdings, Inc. | 1.12B | 1.86% | 757,974 | 785.23M |
| 354 | AORT | Artivion, Inc. | 1.11B | -0.17% | 501,373 | 471.47M |
| 355 | LTGO | Latigo Biotherapeutics, Inc. | 1.11B | -7.73% | 532,593 | - |
| 356 | IRMD | IRADIMED CORPORATION | 1.10B | -0.28% | 138,811 | 86.34M |
| 357 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.10B | -3.26% | 509,363 | 730.02M |
| 358 | CSTL | Castle Biosciences, Inc. | 1.09B | 1.86% | 639,605 | 357.28M |
| 359 | AKTS | Aktis Oncology, Inc. | 1.08B | -1.12% | 277,271 | 10.06M |
| 360 | SPTX | Seaport Therapeutics, Inc. | 1.08B | 7.92% | 488,678 | - |
| 361 | ODTX | Odyssey Therapeutics, Inc. | 1.06B | -0.98% | 334,166 | 99.00K |
| 362 | MGTX | MeiraGTx Holdings plc | 1.06B | -1.17% | 1,423,927 | 397.50M |
| 363 | JANX | Janux Therapeutics, Inc. | 1.06B | 1.95% | 772,494 | 24.00M |
| 364 | TDOC | Teladoc Health, Inc. | 1.05B | 0.87% | 3,407,544 | 2.49B |
| 365 | ENOV | Enovis Corporation | 1.05B | -1.03% | 1,942,984 | 2.30B |
| 366 | PRCT | PROCEPT BioRobotics Corporation | 1.04B | - | 1,594,598 | 337.34M |
| 367 | ANL | Adlai Nortye Group Ltd. | 1.03B | 2.24% | 93,948 | 18.06M |
| 368 | GLUE | Monte Rosa Therapeutics, Inc. | 1.02B | 1.62% | 913,959 | 28.73M |
| 369 | ANRO | Alto Neuroscience, Inc. | 1.00B | -3.95% | 891,623 | - |
| 370 | BBNX | Beta Bionics, Inc. | 999.14M | -2.22% | 1,456,388 | 119.01M |
| 371 | PCRX | Pacira BioSciences, Inc. | 998.54M | -2.34% | 628,469 | 746.16M |
| 372 | MLTX | MoonLake Immunotherapeutics | 995.75M | 2.18% | 1,994,435 | - |
| 373 | CGEM | Cullinan Therapeutics, Inc. | 987.84M | 0.79% | 1,067,168 | - |
| 374 | LMRI | Lumexa Imaging Holdings, Inc. | 984.77M | -0.10% | 781,552 | 1.04B |
| 375 | SLBT | SL Science Holding Limited | 969.45M | -7.10% | 27,359 | 3.27M |
| 376 | CRVS | Corvus Pharmaceuticals, Inc. | 969.07M | -2.04% | 875,847 | - |
| 377 | ALMS | Alumis Inc. | 956.53M | 1.37% | 1,403,010 | 7.40M |
| 378 | KURA | Kura Oncology, Inc. | 952.77M | -0.93% | 1,871,402 | 77.23M |
| 379 | ABUS | Arbutus Biopharma Corporation | 945.71M | 1.92% | 16,876,018 | 181.72M |
| 380 | CBLL | CeriBell, Inc. | 936.04M | -1.89% | 336,291 | 101.96M |
| 381 | APMD | Apnimed, Inc. | 912.13M | -8.33% | 669,623 | 115.12M |
| 382 | HSTM | HealthStream, Inc. | 909.00M | -0.10% | 223,160 | 321.12M |
| 383 | RIGL | Rigel Pharmaceuticals, Inc. | 899.44M | -1.51% | 252,210 | 276.79M |
| 384 | HELP | Cybin Inc. | 897.91M | -3.23% | 823,390 | - |
| 385 | JBIO | Jade Biosciences, Inc. | 893.54M | -0.92% | 930,921 | - |
| 386 | IVA | Inventiva S.A. | 884.11M | 12.16% | 4,802,651 | 2.81M |
| 387 | SANA | Sana Biotechnology, Inc. | 872.64M | 0.17% | 3,245,650 | - |
| 388 | SGP | SpyGlass Pharma, Inc. | 869.65M | 2.20% | 79,569 | - |
| 389 | DNA | Ginkgo Bioworks Holdings, Inc. | 863.98M | 7.27% | 4,652,869 | 132.42M |
| 390 | ARDX | Ardelyx, Inc. | 852.22M | 0.88% | 4,412,508 | 450.89M |
| 391 | OBX | Obsidian Therapeutics, Inc. | 848.14M | -5.83% | 351,595 | - |
| 392 | SIBN | SI-BONE, Inc. | 842.59M | -1.83% | 640,214 | 213.60M |
| 393 | LXRX | Lexicon Pharmaceuticals, Inc. | 834.29M | -0.27% | 1,744,200 | 41.47M |
| 394 | ACHV | Achieve Life Sciences, Inc. | 832.48M | 5.20% | 2,378,245 | - |
| 395 | AVTX | Avalo Therapeutics, Inc. | 822.15M | -1.60% | 1,432,738 | 59.00K |
| 396 | INMD | InMode Ltd. | 814.50M | -0.35% | 378,732 | 374.63M |
| 397 | ANNX | Annexon, Inc. | 801.92M | 2.42% | 4,411,914 | - |
| 398 | CADL | Candel Therapeutics, Inc. | 798.85M | -4.04% | 1,268,853 | - |
| 399 | FDMT | 4D Molecular Therapeutics, Inc. | 790.54M | -1.24% | 1,037,056 | 92.01M |
| 400 | GERN | Geron Corporation | 790.24M | -0.81% | 9,443,027 | 204.56M |
| 401 | DSGN | Design Therapeutics, Inc. | 786.65M | -0.40% | 589,520 | - |
| 402 | ATTO | Attovia Therapeutics, Inc. | 782.46M | -5.62% | 769,561 | 1.80M |
| 403 | VREX | Varex Imaging Corporation | 777.63M | -0.11% | 872,049 | 865.00M |
| 404 | GYRE | Gyre Therapeutics, Inc. | 777.23M | 0.14% | 159,793 | 109.82M |
| 405 | SLDB | Solid Biosciences Inc. | 775.24M | 0.98% | 1,711,185 | - |
| 406 | CTKB | Cytek Biosciences, Inc. | 774.70M | 3.47% | 1,324,207 | 206.71M |
| 407 | ACRS | Aclaris Therapeutics, Inc. | 774.27M | -0.38% | 2,263,474 | 8.22M |
| 408 | AHG | Akso Health Group | 771.03M | 30.25% | 5,643,301 | 13.83M |
| 409 | FTH | Faeth Therapeutics, Inc. | 768.49M | 5.95% | 356,524 | - |
| 410 | AVR | Anteris Technologies Global Corp. | 757.25M | 2.37% | 976,392 | 2.24M |
| 411 | OLMA | Olema Pharmaceuticals, Inc. | 755.98M | 1.17% | 1,542,813 | - |
| 412 | AHCO | AdaptHealth Corp. | 752.43M | -0.53% | 2,079,293 | 3.36B |
| 413 | GMRS | GMR Solutions Inc. | 748.46M | -2.13% | 1,419,844 | 5.88B |
| 414 | IMMX | Immix Biopharma, Inc. | 744.37M | -1.28% | 2,409,076 | - |
| 415 | PACB | Pacific Biosciences of California, Inc. | 736.67M | 29.51% | 80,386,308 | 159.27M |
| 416 | WVE | Wave Life Sciences, Inc. | 729.08M | 1.65% | 4,209,281 | 65.37M |
| 417 | VSTM | Verastem, Inc. | 729.04M | 1.64% | 1,568,538 | 87.53M |
| 418 | QDEL | QuidelOrtho Corporation | 722.79M | -0.57% | 1,376,265 | 2.67B |
| 419 | OABI | OmniAb, Inc. | 721.14M | 4.64% | 1,928,780 | 38.46M |
| 420 | SOPH | SOPHiA GENETICS SA | 713.37M | 0.96% | 471,239 | 86.17M |
| 421 | PHAR | Pharming Group N.V. | 713.09M | -0.20% | 12,321 | 366.48M |
| 422 | COLL | Collegium Pharmaceutical, Inc. | 710.36M | -1.84% | 811,564 | 808.21M |
| 423 | ETRA | Electra Therapeutics, Inc. | 706.13M | -0.88% | 925,708 | - |
| 424 | DBVT | DBV Technologies S.A. | 696.94M | 1.82% | 400,954 | 5.04M |
| 425 | NVCT | Nuvectis Pharma, Inc. | 688.12M | 2.87% | 240,278 | - |
| 426 | STTK | Shattuck Labs, Inc. | 684.48M | 4.28% | 3,356,723 | 1.00M |
| 427 | MDXG | MiMedx Group, Inc. | 679.24M | -0.21% | 1,028,517 | 355.17M |
| 428 | CLYM | Climb Bio, Inc. | 658.79M | -0.26% | 1,411,231 | - |
| 429 | SLN | Silence Therapeutics plc | 658.09M | 1.20% | 1,356,284 | 615.00K |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 656.00M | -4.57% | 1,662,299 | 389.32M |
| 431 | ZVRA | Zevra Therapeutics, Inc. | 651.44M | -3.26% | 1,818,341 | 136.07M |
| 432 | AURA | Aura Biosciences, Inc. | 651.27M | 2.11% | 677,458 | - |
| 433 | STLN | Starling Oncology, Inc. | 644.11M | -2.92% | 946,919 | 587.24M |
| 434 | PHR | Phreesia, Inc. | 641.19M | 3.20% | 619,229 | 507.79M |
| 435 | ANGO | AngioDynamics, Inc. | 635.69M | -1.41% | 634,476 | 320.17M |
| 436 | EVO | Evotec SE | 625.74M | 4.27% | 101,615 | 819.47M |
| 437 | CBIO | Crescent Biopharma, Inc. | 624.47M | -1.15% | 289,531 | 11.88M |
| 438 | SGMT | Sagimet Biosciences Inc. | 614.13M | 5.89% | 5,453,770 | - |
| 439 | FLGT | Fulgent Genetics, Inc. | 605.89M | -0.27% | 273,542 | 323.93M |
| 440 | EPRX | Eupraxia Pharmaceuticals Inc. | 603.06M | 9.51% | 1,279,354 | - |
| 441 | CRMD | CorMedix Inc. | 600.17M | -2.90% | 948,364 | 462.25M |
| 442 | SSII | SS Innovations International, Inc. | 597.15M | 3.11% | 151,406 | 52.40M |
| 443 | CTMX | CytomX Therapeutics, Inc. | 592.69M | -1.09% | 3,220,701 | 18.30M |
| 444 | BLSM | BlossomHill Therapeutics, Inc. | 592.47M | -12.77% | 362,167 | - |
| 445 | WEAV | Weave Communications, Inc. | 590.39M | 0.27% | 980,377 | 257.79M |
| 446 | VALN | Valneva SE | 583.63M | 0.73% | 5,839 | 163.30M |
| 447 | KIDS | OrthoPediatrics Corp. | 581.46M | -2.15% | 149,844 | 252.72M |
| 448 | AQST | Aquestive Therapeutics, Inc. | 581.12M | -0.86% | 2,412,533 | 54.09M |
| 449 | PHAT | Phathom Pharmaceuticals, Inc. | 579.84M | -0.82% | 809,201 | 239.66M |
| 450 | OCS | Oculis Holding AG | 576.58M | 2.30% | 434,740 | 1.45M |
| 451 | MPLT | MapLight Therapeutics, Inc. | 566.32M | 0.39% | 303,257 | - |
| 452 | NGNE | Neurogene Inc. | 556.72M | -2.01% | 160,126 | 925.00K |
| 453 | ALT | Altimmune, Inc. | 556.32M | -3.70% | 4,922,487 | 31.00K |
| 454 | DCTH | Delcath Systems, Inc. | 554.14M | 0.76% | 300,801 | 95.42M |
| 455 | ALLO | Allogene Therapeutics, Inc. | 552.79M | -1.23% | 8,132,423 | 4.64M |
| 456 | CAPR | Capricor Therapeutics, Inc. | 550.58M | 10.50% | 20,566,626 | 11.13M |
| 457 | AGMB | AgomAb Therapeutics NV | 546.65M | 5.41% | 133,706 | - |
| 458 | PRME | Prime Medicine, Inc. | 543.50M | -1.13% | 3,132,453 | 4.07M |
| 459 | SENS | Senseonics Holdings, Inc. | 537.73M | 1.19% | 922,471 | 48.55M |
| 460 | MNPR | Monopar Therapeutics Inc. | 534.76M | -0.41% | 226,312 | - |
| 461 | BWAY | BrainsWay Ltd. | 531.03M | -2.08% | 70,719 | 60.70M |
| 462 | GLAS | Glass House Brands Inc. | 528.70M | -17.38% | 5,539,991 | 176.98M |
| 463 | EOLS | Evolus, Inc. | 528.40M | 0.13% | 624,366 | 316.49M |
| 464 | YDES | YD Bio Limited | 525.57M | -2.50% | 205,694 | 1.24M |
| 465 | AUTL | Autolus Therapeutics plc | 516.36M | 4.30% | 1,159,394 | 117.39M |
| 466 | SGHT | Sight Sciences, Inc. | 515.62M | 0.11% | 571,346 | 83.38M |
| 467 | TLRY | Tilray Brands, Inc. | 513.72M | -5.06% | 7,534,623 | 915.45M |
| 468 | PBYI | Puma Biotechnology, Inc. | 512.59M | 1.53% | 398,968 | 231.24M |
| 469 | MASS | 908 Devices Inc. | 510.06M | 4.14% | 414,118 | 60.84M |
| 470 | ARVN | Arvinas, Inc. | 505.76M | 3.13% | 1,061,021 | 316.70M |
| 471 | TCMD | Tactile Systems Technology, Inc. | 504.92M | -1.07% | 234,324 | 350.31M |
| 472 | CTNM | Contineum Therapeutics, Inc. | 504.88M | 16.70% | 1,597,800 | - |
| 473 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 474 | ENTX | Entera Bio Ltd. | 503.84M | 8.18% | 520,976 | 42.00K |
| 475 | PROK | ProKidney Corp. | 501.86M | 1.84% | 1,196,615 | 818.00K |
| 476 | KMDA | Kamada Ltd. | 498.59M | -2.76% | 99,005 | 191.85M |
| 477 | RGNX | REGENXBIO Inc. | 497.08M | 1.07% | 1,788,568 | 174.48M |
| 478 | DRUG | Bright Minds Biosciences Inc. | 488.67M | 0.16% | 79,829 | - |
| 479 | OVID | Ovid Therapeutics Inc. | 486.29M | -1.97% | 1,442,691 | 1.58M |
| 480 | CERS | Cerus Corporation | 479.63M | -3.64% | 1,932,353 | 221.55M |
| 481 | ASMB | Assembly Biosciences, Inc. | 478.27M | 0.04% | 221,147 | 74.85M |
| 482 | TKNO | Alpha Teknova, Inc. | 477.83M | -1.98% | 288,029 | 43.70M |
| 483 | NPCE | NeuroPace, Inc. | 472.30M | -1.29% | 120,884 | 106.99M |
| 484 | NRC | NRC Health | 468.71M | 0.67% | 142,652 | 140.00M |
| 485 | TECX | Tectonic Therapeutic, Inc. | 455.30M | -0.21% | 251,634 | - |
| 486 | SRTA | Strata Critical Medical, Inc. | 452.07M | 0.20% | 798,317 | 255.98M |
| 487 | AGEN | Agenus Inc. | 447.05M | 0.40% | 1,367,324 | 132.69M |
| 488 | DMAC | DiaMedica Therapeutics Inc. | 445.97M | 0.85% | 219,108 | - |
| 489 | EIKN | Eikon Therapeutics, Inc. | 435.49M | 1.64% | 585,753 | - |
| 490 | RZLT | Rezolute, Inc. | 434.27M | 1.22% | 1,702,788 | - |
| 491 | PRTA | Prothena Corporation plc | 430.20M | -4.56% | 634,780 | 54.53M |
| 492 | TTRX | Turn Therapeutics Inc. | 428.65M | 7.31% | 88,716 | - |
| 493 | SPRY | ARS Pharmaceuticals, Inc. | 428.62M | -2.05% | 1,298,239 | 116.93M |
| 494 | KYTX | Kyverna Therapeutics, Inc. | 420.54M | -0.58% | 746,992 | - |
| 495 | AVIR | Atea Pharmaceuticals, Inc. | 417.87M | 0.58% | 296,282 | - |
| 496 | MYGN | Myriad Genetics, Inc. | 412.25M | 1.89% | 1,504,783 | 806.60M |
| 497 | CCCC | C4 Therapeutics, Inc. | 409.67M | 6.39% | 2,609,340 | 35.04M |
| 498 | PRLD | Prelude Therapeutics Incorporated | 402.71M | -1.26% | 703,218 | 22.42M |
| 499 | IRD | Opus Genetics, Inc. | 402.67M | -2.32% | 2,458,483 | 9.86M |
| 500 | RLMD | Relmada Therapeutics, Inc. | 402.15M | 1.07% | 999,526 | - |